Hair Restoration
Treatment in Delhi

Six decisions before hair restoration

A realistic summary for AGA, telogen effluvium, alopecia areata, scarring alopecia, devices, and Indian-scalp safety.

When to consult for hair restoration

Consult when scalp visibility, parting widening, hairline recession, increased shedding, patchy loss, or post-pregnancy hair change persists despite home routines.

Clinical clue: consultation threshold

In this consultation threshold step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and decides whether non-surgical restoration, hormonal evaluation, scarring-alopecia control, or surgical referral is needed. Detail 1-1 keeps the counselling specific.

Why it matters: consultation threshold

In this consultation threshold step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and decides whether non-surgical restoration, hormonal evaluation, scarring-alopecia control, or surgical referral is needed. Detail 1-2 keeps the counselling specific.

Doctor decision: consultation threshold

In this consultation threshold step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and decides whether non-surgical restoration, hormonal evaluation, scarring-alopecia control, or surgical referral is needed. Detail 1-3 keeps the counselling specific.

Depth checkpoint 1: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section when-to-see keeps expectations honest and avoids over-promising density change.

Additional clinical depth for when-to-see: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 1: For when-to-see, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 1: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Why hair density changes

Hair density changes with androgenetic biology, telogen effluvium triggers, autoimmune patterns, scarring inflammation, hormonal phase, nutritional status, medications, and scalp conditions.

Clinical clue: driver mapping

In this driver mapping step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and selects the right level of intervention. Detail 3-1 keeps the counselling specific.

Why it matters: driver mapping

In this driver mapping step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and selects the right level of intervention. Detail 3-2 keeps the counselling specific.

Doctor decision: driver mapping

In this driver mapping step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and selects the right level of intervention. Detail 3-3 keeps the counselling specific.

Depth checkpoint 3: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section causes keeps expectations honest and avoids over-promising density change.

Additional clinical depth for causes: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 3: For causes, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 3: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

AGA versus telogen effluvium

Androgenetic alopecia is a chronic miniaturisation pattern; telogen effluvium is a reactive shedding pattern. Different routes serve different patterns.

Clinical clue: category clarity planning

In this category clarity planning step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and keeps results honest. Detail 5-1 keeps the counselling specific.

Why it matters: category clarity planning

In this category clarity planning step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and keeps results honest. Detail 5-2 keeps the counselling specific.

Doctor decision: category clarity planning

In this category clarity planning step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and keeps results honest. Detail 5-3 keeps the counselling specific.

Decision checkpoint for category clarity planning

This checkpoint confirms whether the chosen restoration route matches the patient diagnosis. Scarring alopecias, severe AGA without donor area, or active immune flares are routed differently.

Depth checkpoint 5: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section aga-vs-shedding keeps expectations honest and avoids over-promising density change.

Additional clinical depth for aga-vs-shedding: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 5: For aga-vs-shedding, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 5: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Patchy loss and immunology overlap

Alopecia areata is autoimmune patchy loss with cyclical regrowth potential; treatment is dermatology-supervised and adjusted by extent.

Clinical clue: alopecia areata planning

In this alopecia areata planning step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and stops generic transplant or product approaches that do not fit immune patterns. Detail 7-1 keeps the counselling specific.

Why it matters: alopecia areata planning

In this alopecia areata planning step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and stops generic transplant or product approaches that do not fit immune patterns. Detail 7-2 keeps the counselling specific.

Doctor decision: alopecia areata planning

In this alopecia areata planning step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and stops generic transplant or product approaches that do not fit immune patterns. Detail 7-3 keeps the counselling specific.

Depth checkpoint 7: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section alopecia-areata keeps expectations honest and avoids over-promising density change.

Additional clinical depth for alopecia-areata: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 7: For alopecia-areata, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 7: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Who may be suitable

Suitable patients have a defined diagnosis, realistic expectations, willingness to commit to maintenance, and acceptable scalp condition.

Clinical clue: suitability scoring

In this suitability scoring step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and matches the route to the diagnosis. Detail 9-1 keeps the counselling specific.

Why it matters: suitability scoring

In this suitability scoring step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and matches the route to the diagnosis. Detail 9-2 keeps the counselling specific.

Doctor decision: suitability scoring

In this suitability scoring step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and matches the route to the diagnosis. Detail 9-3 keeps the counselling specific.

Depth checkpoint 9: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section suitability keeps expectations honest and avoids over-promising density change.

Additional clinical depth for suitability: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 9: For suitability, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 9: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Hair restoration treatment ladder

Plans may include scalp care, topical minoxidil, oral medications where appropriate (finasteride, dutasteride, spironolactone in selected women), PRP discussion, microneedling, low-level light therapy, or surgical referral.

Clinical clue: treatment ladder

In this treatment ladder step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and matches the route to driver and safety. Detail 11-1 keeps the counselling specific.

Why it matters: treatment ladder

In this treatment ladder step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and matches the route to driver and safety. Detail 11-2 keeps the counselling specific.

Doctor decision: treatment ladder

In this treatment ladder step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and matches the route to driver and safety. Detail 11-3 keeps the counselling specific.

Depth checkpoint 11: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section treatments keeps expectations honest and avoids over-promising density change.

Additional clinical depth for treatments: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 11: For treatments, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 11: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Devices for hair restoration

Microneedling, PRP discussion, low-level light therapy, and exosome discussion may support selected patients with realistic expectations.

Clinical clue: device planning

In this device planning step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and keeps energy and needle-based care safe in pigmentation-prone scalp. Detail 13-1 keeps the counselling specific.

Why it matters: device planning

In this device planning step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and keeps energy and needle-based care safe in pigmentation-prone scalp. Detail 13-2 keeps the counselling specific.

Doctor decision: device planning

In this device planning step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and keeps energy and needle-based care safe in pigmentation-prone scalp. Detail 13-3 keeps the counselling specific.

Depth checkpoint 13: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section devices keeps expectations honest and avoids over-promising density change.

Additional clinical depth for devices: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 13: For devices, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 13: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Hair-transplant discussion and referral boundaries

Hair-transplant referral depends on diagnosis, donor area, stability, age, and patient priorities.

Clinical clue: transplant referral discussion

In this transplant referral discussion step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and separates non-surgical, regenerative, and surgical routes. Detail 15-1 keeps the counselling specific.

Why it matters: transplant referral discussion

In this transplant referral discussion step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and separates non-surgical, regenerative, and surgical routes. Detail 15-2 keeps the counselling specific.

Doctor decision: transplant referral discussion

In this transplant referral discussion step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and separates non-surgical, regenerative, and surgical routes. Detail 15-3 keeps the counselling specific.

Decision checkpoint for transplant referral discussion

This checkpoint confirms whether the chosen restoration route matches the patient diagnosis. Scarring alopecias, severe AGA without donor area, or active immune flares are routed differently.

Depth checkpoint 15: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section transplant-discussion keeps expectations honest and avoids over-promising density change.

Additional clinical depth for transplant-discussion: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 15: For transplant-discussion, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 15: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Home care that supports restoration outcomes

Home care supports scalp condition, gentle washing, sun protection, and stress and sleep hygiene but cannot replace targeted treatment in active loss.

Clinical clue: home-care planning

In this home-care planning step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and aligns daily routines with the active plan. Detail 17-1 keeps the counselling specific.

Why it matters: home-care planning

In this home-care planning step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and aligns daily routines with the active plan. Detail 17-2 keeps the counselling specific.

Doctor decision: home-care planning

In this home-care planning step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and aligns daily routines with the active plan. Detail 17-3 keeps the counselling specific.

Depth checkpoint 17: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section home-care keeps expectations honest and avoids over-promising density change.

Additional clinical depth for home-care: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 17: For home-care, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 17: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Safety, contraindications, and consent

Safety includes scalp anatomy, vascular awareness, skin type, prior procedures, medical history, medicines, and realistic consent.

Clinical clue: safety review

In this safety review step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports informed consent in writing. Detail 19-1 keeps the counselling specific.

Why it matters: safety review

In this safety review step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports informed consent in writing. Detail 19-2 keeps the counselling specific.

Doctor decision: safety review

In this safety review step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports informed consent in writing. Detail 19-3 keeps the counselling specific.

Depth checkpoint 19: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section safety keeps expectations honest and avoids over-promising density change.

Additional clinical depth for safety: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 19: For safety, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 19: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Maintenance and lifelong adherence

Maintenance depends on diagnosis, adherence, hormonal phase, and the treatment route used. AGA usually needs lifelong support.

Clinical clue: maintenance planning

In this maintenance planning step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and preserves improvement without overtreatment. Detail 21-1 keeps the counselling specific.

Why it matters: maintenance planning

In this maintenance planning step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and preserves improvement without overtreatment. Detail 21-2 keeps the counselling specific.

Doctor decision: maintenance planning

In this maintenance planning step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and preserves improvement without overtreatment. Detail 21-3 keeps the counselling specific.

Depth checkpoint 21: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section maintenance keeps expectations honest and avoids over-promising density change.

Additional clinical depth for maintenance: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 21: For maintenance, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 21: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Specialist dermatologists for hair restoration

Doctor-led restoration balances patient preference with diagnosis, safety, and surgical referral boundaries.

Clinical clue: specialist selection

In this specialist selection step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and documents who reviews each step. Detail 23-1 keeps the counselling specific.

Why it matters: specialist selection

In this specialist selection step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and documents who reviews each step. Detail 23-2 keeps the counselling specific.

Doctor decision: specialist selection

In this specialist selection step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and documents who reviews each step. Detail 23-3 keeps the counselling specific.

Depth checkpoint 23: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section doctors keeps expectations honest and avoids over-promising density change.

Additional clinical depth for doctors: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 23: For doctors, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 23: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

How to prepare for consultation

Bring scalp photos, prior treatment details, family-history notes, hormonal history, recent labs, and the exact restoration concern you want assessed.

Clinical clue: consultation preparation

In this consultation preparation step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and saves time and improves planning. Detail 25-1 keeps the counselling specific.

Why it matters: consultation preparation

In this consultation preparation step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and saves time and improves planning. Detail 25-2 keeps the counselling specific.

Doctor decision: consultation preparation

In this consultation preparation step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and saves time and improves planning. Detail 25-3 keeps the counselling specific.

Depth checkpoint 25: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section consultation-prep keeps expectations honest and avoids over-promising density change.

Additional clinical depth for consultation-prep: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 25: For consultation-prep, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 25: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Photo documentation and privacy

Restoration changes are angle, lighting, parting, and hairstyle sensitive, so photos need consistency and consent.

Clinical clue: photo documentation

In this photo documentation step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports clinical review without misleading public claims. Detail 27-1 keeps the counselling specific.

Why it matters: photo documentation

In this photo documentation step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports clinical review without misleading public claims. Detail 27-2 keeps the counselling specific.

Doctor decision: photo documentation

In this photo documentation step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports clinical review without misleading public claims. Detail 27-3 keeps the counselling specific.

Depth checkpoint 27: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section photo-proof keeps expectations honest and avoids over-promising density change.

Additional clinical depth for photo-proof: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 27: For photo-proof, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 27: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Medical review and content governance

This page is educational and supports consultation-first hair restoration planning.

Clinical clue: governance positioning

In this governance positioning step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and documents named-reviewer accountability. Detail 29-1 keeps the counselling specific.

Why it matters: governance positioning

In this governance positioning step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and documents named-reviewer accountability. Detail 29-2 keeps the counselling specific.

Doctor decision: governance positioning

In this governance positioning step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and documents named-reviewer accountability. Detail 29-3 keeps the counselling specific.

Depth checkpoint 29: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section governance keeps expectations honest and avoids over-promising density change.

Additional clinical depth for governance: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 29: For governance, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 29: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Hair restoration timing for events

Restoration responses develop over months, so last-minute density change before events is not realistic.

Clinical clue: event timing

In this event timing step, the dermatologist compares diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports realistic pre-event planning. Detail 31-1 keeps the counselling specific.

Why it matters: event timing

In this event timing step, the dermatologist documents diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports realistic pre-event planning. Detail 31-2 keeps the counselling specific.

Doctor decision: event timing

In this event timing step, the dermatologist prioritises diagnosis (androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia, post-inflammatory hair loss), trichoscopy findings, hormonal pattern, nutritional status, scalp condition, and patient priorities. This matters because hair restoration outcomes are shaped by underlying diagnosis, follicular reserve, scalp biology, and adherence rather than by one product or device. Stable AGA, ongoing telogen effluvium, patchy alopecia areata, and scarring alopecias all behave differently, yet each presentation needs a different sequence. The consultation turns the restoration request into a safe route and supports realistic pre-event planning. Detail 31-3 keeps the counselling specific.

Depth checkpoint 31: Hair restoration planning uses a driver-specific endpoint. AGA care looks for stabilisation and partial regrowth. Telogen effluvium care looks for trigger control and shedding reduction. Alopecia areata care looks for repigmentation cycles. Scarring alopecia care looks for disease control before regrowth. The endpoint chosen in section event-timing keeps expectations honest and avoids over-promising density change.

Additional clinical depth for event-timing: The clinician also weighs trichoscopy, hair-pull test, scalp examination, hormonal screening, nutritional labs, prior treatments, scalp condition, sensitivity, budget, downtime, and prior treatment history against the patient goal. This is especially important when patients arrive expecting transplant-level density change from a non-surgical plan. One restoration driver is treated at a time before adding another intervention.

Second depth layer 31: For event-timing, the doctor explains what the proposed route cannot change. Devices and topicals do not regrow scarred follicles, do not reverse advanced AGA, and do not eliminate the need for maintenance in chronic patterns. Clear negative counselling prevents treatment drift and helps the patient choose conservative care, staged clinic treatment, dermatology supervision, or surgical hair-transplant referral.

Additional restoration refinement 31: The review returns to the original restoration driver rather than a generic density ideal. If the patient wanted AGA stabilised, the doctor checks adherence, trichoscopy change, and side effects. If the patient wanted shedding controlled, the doctor checks trigger resolution and pull-test trend. This keeps treatment grounded in scalp biology.

Good fit, caution, and delay decisions

Specialist dermatologist team

Glossary terms for hair restoration

Hair restoration

A diagnosis-led plan to stabilise or partially regrow hair density.

Androgenetic alopecia (AGA)

Genetically driven miniaturisation pattern affecting hair density.

Telogen effluvium

Reactive shedding triggered by illness, stress, surgery, postpartum, or medication.

Alopecia areata

Autoimmune patchy hair loss with cyclical regrowth potential.

Scarring alopecia

Inflammation-driven hair loss that destroys follicles and needs medical control.

Trichoscopy

Magnified scalp examination used to support diagnosis.

Hair-pull test

A clinical test that measures shedding tendency.

Miniaturisation

Progressive thinning of individual hair follicles in AGA.

Donor area

The retained hair zone used as a source in hair-transplant surgery.

Minoxidil

A topical medication used for selected hair loss patterns.

Finasteride

An oral medication considered for selected male AGA cases.

Dutasteride

An oral medication considered for selected AGA cases under specialist care.

Spironolactone

An oral option considered for selected female hormonal hair loss patterns.

PRP

Platelet-rich plasma considered for selected restoration plans.

Exosome therapy

An emerging modality discussed cautiously in selected patients.

Microneedling

A controlled needle-based procedure that may pair with restoration plans.

Low-level light therapy

A device option used in selected hair-density plans.

Hair transplant

Surgical relocation of follicles by a qualified hair transplant surgeon.

FUE

Follicular unit extraction technique used in hair-transplant surgery.

FUT

Follicular unit transplantation strip technique used in hair-transplant surgery.

Postpartum hair loss

Telogen effluvium-pattern shedding after delivery.

PCOS

Polycystic ovary syndrome that can drive female hair-loss patterns.

Thyroid pattern

Thyroid-related shedding pattern relevant to restoration planning.

Seborrhoeic dermatitis

A scalp condition that can affect tolerability and perceived loss.

Folliculitis

Inflammation of hair follicles that can complicate restoration plans.

Adherence

Consistent use of prescribed treatment over months to years.

Maintenance

Ongoing care to preserve restoration improvement.

Contraindication

A reason to delay or avoid treatment.

Endpoint

The realistic treatment goal chosen after assessment.

Referral

Routing to another specialist when outside dermatology scope.

Honest answers before you book

Common questions about hair restoration, AGA, telogen effluvium, alopecia areata, devices, transplant boundaries, safety, and maintenance.